Diet Drug Safe for Heart: FDA

Monday, 25 Nov 2013 12:52 PM

 

Share:
  Comment  |
   Contact Us  |
  Print  
|  A   A  
  Copy Shortlink

Orexigen Therapeutics Inc said study data showed its experimental obesity drug did not increase heart-related risks, sending its shares up 28 percent in premarket trading.
 
The drug, Contrave, was previously denied approval by the U.S. Food and Drug Administration, which cited potential heart risks. The FDA had requested an additional trial.
 
The company said on Monday it would resubmit its application for U.S. marketing approval for Contrave in the next few weeks, with a decision expected by June.
 
An interim analysis of the heart-risk study, named Light, showed that overweight and obese patients receiving Contrave did not have a higher heart risk, compared with those on a placebo.
 
"The interim analysis of the Light study clearly achieved the goal set by the FDA," Chief Executive Michael Narachi said in a statement.
 
Obesity has assumed epidemic proportions in the United States, creating a huge market opportunity for drugmakers.
 
Vivus Inc and Arena Pharmaceuticals Inc already have their obesity pills approved by the FDA. Vivus's Qsymia and Arena's Belviq were approved in mid-2012.
 
However, sales of both drugs till now have been disappointing due to safety concerns, and problems related to reimbursement and earlier obesity treatments.
 

© 2014 Thomson/Reuters. All rights reserved.

Share:
  Comment  |
   Contact Us  |
  Print  
  Copy Shortlink
Around the Web
Join the Newsmax Community
Please review Community Guidelines before posting a comment.
>> Register to share your comments with the community.
>> Login if you are already a member.
blog comments powered by Disqus
 
Email:
Retype Email:
Country
Zip Code:
Privacy: We never share your email.
 
Hot Topics
Follow Newsmax
Like us
on Facebook
Follow us
on Twitter
Add us
on Google Plus
Around the Web
Top Stories
You May Also Like

Only 28% of ALS Ice Bucket Donations Used For Research

Sunday, 31 Aug 2014 11:17 AM

The ice bucket challenge to raise support for ALS research has gone viral in recent weeks, drawing celebrities, everyd . . .

Clockwork Pacemaker Works Without Batteries

Sunday, 31 Aug 2014 10:26 AM

Swiss engineers have developed a prototype battery-less pacemaker based on a self-winding wristwatch. . . .

New Cholesterol Drug Cuts Heart Risk in Half

Sunday, 31 Aug 2014 10:15 AM

A new cholesterol-lowering drug roughly halved the number of heart attacks and strokes in a clinical trial, researchers  . . .

Most Commented

Newsmax, Moneynews, and Independent. American. are registered trademarks of Newsmax Media, Inc. Newsmax TV, NewsmaxWorld, NewsmaxHealth, are trademarks of Newsmax Media, Inc.

 
NEWSMAX.COM
America's News Page
©  Newsmax Media, Inc.
All Rights Reserved